The LANCET Trial: A Trial of Long-acting Insulin Injection to Reduce C-reactive Protein in Patients With Type 2 Diabetes
Clinical trial NCT00366301 · TERMINATED
Trial details
- NCT number
- NCT00366301
- Sponsor
- Brigham and Women's Hospital
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2009-04-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.